SCHEMBL4511548

SCHEMBL4511548

COC(=O)c1cccc(C(=O)c2c(C)c(N)c3ccccn23)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.48
ALDH1A1 P00352 4/20 0.47
MAPT P10636 5/20 0.43
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
HPGD P15428 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
USP2 O75604 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
GAA P10253 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
DAPK3 O43293 1/20 0.41
JAK2 O60674 1/20 0.41
PRKD3 O94806 1/20 0.41
MAP4K4 O95819 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1572767 0.86 HTT (0.54) HTTALDH1A1MAPTKMT2AMEN1
SCHEMBL143620 0.86 HTT (0.48) HTTALDH1A1MAPTKMT2AMEN1
SCHEMBL4501200 0.85 MAPT (0.45) HTTALDH1A1MAPTKMT2AMEN1
SCHEMBL2975685 0.83 DAPK3 (0.54) HTTALDH1A1MAPTKMT2AMEN1
SCHEMBL27737738 0.80 HTT (0.52) HTTALDH1A1MAPTKMT2AMEN1
SCHEMBL1572805 0.80 MAPT (0.47) HTTALDH1A1MAPTKMT2AMEN1
SCHEMBL320893 0.78 MAPT (0.46) HTTALDH1A1MAPTKMT2AMEN1
SCHEMBL1572895 0.76 HTT (0.48) HTTALDH1A1MAPTKMT2AMEN1
SCHEMBL12716665 0.75 HTT (0.53) HTTALDH1A1MAPTKMT2AMEN1
SCHEMBL3597834 0.75 HTT (0.52) HTTALDH1A1MAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9120819-B2 FGF-receptor agonist dimeric compounds SANOFI (FR) 2015-09-01 US disclosed
CN-101384258-B FGF Receptor Agonist Dimeric Compounds SANOFI AVENTIS 2013-06-26 CN disclosed
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS SANOFI-AVENTIS (FR) 2009-03-12 US disclosed
CN-101384258-A FGF receptor agonist dimeric compounds SANOFI AVENTIS (FR) 2009-03-11 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS FGF2, FGFR1, FGF1 HTT 4673/4885ALDH1A1 1044/4885MAPT 3588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.